Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype

So Mee Kwon, Dong-Sik Kim, Nam Hee Won, Soo Jeong Park, Yong Joon Chwae, Ho Chul Kang, Soo Hwan Lee, Eun Joo Baik, Snorri S. Thorgeirsson, Hyun GooWoo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Genomic analyses have revealed the enormous heterogeneity inessentially all cancer types. However, the identification of precisesubtypes, which are biologically informative and clinically useful, remains a challenge. The application of integrative analysis ofmultilayered genomic profiles to define the chromosomal regionsof genomic copy number alterations with concomitant transcriptionalderegulation is posited to provide a promising strategy toidentify driver targets. In this study, we performed an integrativeanalysis of the DNA copy numbers and gene expression profiles ofhepatocellular carcinoma (HCC). By comparing DNA copy numbersbetween HCC subtypes based on gene expression pattern, we revealed the DNA copy number alteration with concordantgene expression changes at 6p21-p24 particularly in the HCCsubtype of aggressive phenotype without expressing stemnessgenes. Among the genes at 6p21-p24, we identified IER3 as apotential driver. The clinical utility of IER3 copy numbers wasdemonstrated by validating its clinical correlation with independentcohorts. In addition, short hairpin RNA-mediated knockdownexperiment revealed the functional relevance of IER3 inliver cancer progression. In conclusion, our results suggest thatgenomic copy number alterations with transcriptional deregulationat 6p21-p24 identify an aggressive HCC phenotype and anovel functional biomarker.

Original languageEnglish
Pages (from-to)1543-1550
Number of pages8
JournalCarcinogenesis
Volume34
Issue number7
DOIs
Publication statusPublished - 2013 Jul 1

Fingerprint

Phenotype
DNA
Transcriptome
Small Interfering RNA
Neoplasms
Biomarkers
Carcinoma
Gene Expression
Genes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. / Kwon, So Mee; Kim, Dong-Sik; Won, Nam Hee; Park, Soo Jeong; Chwae, Yong Joon; Kang, Ho Chul; Lee, Soo Hwan; Baik, Eun Joo; Thorgeirsson, Snorri S.; GooWoo, Hyun.

In: Carcinogenesis, Vol. 34, No. 7, 01.07.2013, p. 1543-1550.

Research output: Contribution to journalArticle

Kwon, SM, Kim, D-S, Won, NH, Park, SJ, Chwae, YJ, Kang, HC, Lee, SH, Baik, EJ, Thorgeirsson, SS & GooWoo, H 2013, 'Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype', Carcinogenesis, vol. 34, no. 7, pp. 1543-1550. https://doi.org/10.1093/carcin/bgt095
Kwon, So Mee ; Kim, Dong-Sik ; Won, Nam Hee ; Park, Soo Jeong ; Chwae, Yong Joon ; Kang, Ho Chul ; Lee, Soo Hwan ; Baik, Eun Joo ; Thorgeirsson, Snorri S. ; GooWoo, Hyun. / Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. In: Carcinogenesis. 2013 ; Vol. 34, No. 7. pp. 1543-1550.
@article{b7d051737b674e0f9d5d700d91949643,
title = "Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype",
abstract = "Genomic analyses have revealed the enormous heterogeneity inessentially all cancer types. However, the identification of precisesubtypes, which are biologically informative and clinically useful, remains a challenge. The application of integrative analysis ofmultilayered genomic profiles to define the chromosomal regionsof genomic copy number alterations with concomitant transcriptionalderegulation is posited to provide a promising strategy toidentify driver targets. In this study, we performed an integrativeanalysis of the DNA copy numbers and gene expression profiles ofhepatocellular carcinoma (HCC). By comparing DNA copy numbersbetween HCC subtypes based on gene expression pattern, we revealed the DNA copy number alteration with concordantgene expression changes at 6p21-p24 particularly in the HCCsubtype of aggressive phenotype without expressing stemnessgenes. Among the genes at 6p21-p24, we identified IER3 as apotential driver. The clinical utility of IER3 copy numbers wasdemonstrated by validating its clinical correlation with independentcohorts. In addition, short hairpin RNA-mediated knockdownexperiment revealed the functional relevance of IER3 inliver cancer progression. In conclusion, our results suggest thatgenomic copy number alterations with transcriptional deregulationat 6p21-p24 identify an aggressive HCC phenotype and anovel functional biomarker.",
author = "Kwon, {So Mee} and Dong-Sik Kim and Won, {Nam Hee} and Park, {Soo Jeong} and Chwae, {Yong Joon} and Kang, {Ho Chul} and Lee, {Soo Hwan} and Baik, {Eun Joo} and Thorgeirsson, {Snorri S.} and Hyun GooWoo",
year = "2013",
month = "7",
day = "1",
doi = "10.1093/carcin/bgt095",
language = "English",
volume = "34",
pages = "1543--1550",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype

AU - Kwon, So Mee

AU - Kim, Dong-Sik

AU - Won, Nam Hee

AU - Park, Soo Jeong

AU - Chwae, Yong Joon

AU - Kang, Ho Chul

AU - Lee, Soo Hwan

AU - Baik, Eun Joo

AU - Thorgeirsson, Snorri S.

AU - GooWoo, Hyun

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Genomic analyses have revealed the enormous heterogeneity inessentially all cancer types. However, the identification of precisesubtypes, which are biologically informative and clinically useful, remains a challenge. The application of integrative analysis ofmultilayered genomic profiles to define the chromosomal regionsof genomic copy number alterations with concomitant transcriptionalderegulation is posited to provide a promising strategy toidentify driver targets. In this study, we performed an integrativeanalysis of the DNA copy numbers and gene expression profiles ofhepatocellular carcinoma (HCC). By comparing DNA copy numbersbetween HCC subtypes based on gene expression pattern, we revealed the DNA copy number alteration with concordantgene expression changes at 6p21-p24 particularly in the HCCsubtype of aggressive phenotype without expressing stemnessgenes. Among the genes at 6p21-p24, we identified IER3 as apotential driver. The clinical utility of IER3 copy numbers wasdemonstrated by validating its clinical correlation with independentcohorts. In addition, short hairpin RNA-mediated knockdownexperiment revealed the functional relevance of IER3 inliver cancer progression. In conclusion, our results suggest thatgenomic copy number alterations with transcriptional deregulationat 6p21-p24 identify an aggressive HCC phenotype and anovel functional biomarker.

AB - Genomic analyses have revealed the enormous heterogeneity inessentially all cancer types. However, the identification of precisesubtypes, which are biologically informative and clinically useful, remains a challenge. The application of integrative analysis ofmultilayered genomic profiles to define the chromosomal regionsof genomic copy number alterations with concomitant transcriptionalderegulation is posited to provide a promising strategy toidentify driver targets. In this study, we performed an integrativeanalysis of the DNA copy numbers and gene expression profiles ofhepatocellular carcinoma (HCC). By comparing DNA copy numbersbetween HCC subtypes based on gene expression pattern, we revealed the DNA copy number alteration with concordantgene expression changes at 6p21-p24 particularly in the HCCsubtype of aggressive phenotype without expressing stemnessgenes. Among the genes at 6p21-p24, we identified IER3 as apotential driver. The clinical utility of IER3 copy numbers wasdemonstrated by validating its clinical correlation with independentcohorts. In addition, short hairpin RNA-mediated knockdownexperiment revealed the functional relevance of IER3 inliver cancer progression. In conclusion, our results suggest thatgenomic copy number alterations with transcriptional deregulationat 6p21-p24 identify an aggressive HCC phenotype and anovel functional biomarker.

UR - http://www.scopus.com/inward/record.url?scp=84880257575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880257575&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgt095

DO - 10.1093/carcin/bgt095

M3 - Article

C2 - 23508637

AN - SCOPUS:84880257575

VL - 34

SP - 1543

EP - 1550

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 7

ER -